Tag: product candidates

November 25, 2018

What is In-licensing?

In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
October 14, 2018

10 Drugs Going Off Patent in 2018

A look at 10 drugs going off patent in 2018, plus an overview of what loss of exclusivity means for...
May 23, 2018

Providing Non-Exclusive Licenses Makes Zymeworks “Lucky,” Says CEO

The Investing News Network spoke with Zymeworks CEO Ali Tehrani at the Bloom Burton & Co. Health Care Conference, which...
May 9, 2018

AnaptysBio Announces First Quarter 2018 Financial Results and Provides Pipeline Updates

AnaptysBio (Nasdaq:ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, reported operating...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 18, 2018

Biotech Update: Q1 2018 in Review

With Q1 2018 behind us, here the Investing News Network looks back on some of the biggest trends of the...
April 13, 2018

EyeGate Announces $11.25 Million Public Offering

EyeGate Pharmaceuticals (NASDAQ:EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for treating diseases and disorders of the...